Sofiva Genomics Co.,Ltd. (TPEX:6615)
30.80
-0.20 (-0.65%)
Sep 10, 2025, 12:40 PM CST
Sofiva Genomics Revenue
Sofiva Genomics had revenue of 100.68M TWD in the quarter ending June 30, 2025, a decrease of -17.85%. This brings the company's revenue in the last twelve months to 406.32M, down -15.05% year-over-year. In the year 2024, Sofiva Genomics had annual revenue of 453.31M, down -2.89%.
Revenue (ttm)
406.32M
Revenue Growth
-15.05%
P/S Ratio
1.64
Revenue / Employee
n/a
Employees
n/a
Market Cap
665.08M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 453.31M | -13.49M | -2.89% |
Dec 31, 2023 | 466.80M | -28.98M | -5.84% |
Dec 31, 2022 | 495.78M | -12.64M | -2.49% |
Dec 31, 2021 | 508.42M | 19.55M | 4.00% |
Dec 31, 2020 | 488.87M | -20.58M | -4.04% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Caliway Biopharmaceuticals | 44.83M |
PharmaEssentia | 12.63B |
Bora Pharmaceuticals Co., LTD. | 21.32B |
Lotus Pharmaceutical | 19.12B |
Lumosa Therapeutics | 37.25M |
Oneness Biotech | 112.57M |
Polaris Group | 64.02M |
Pell Bio-Med Technology | 27.43M |